| Key Financial Ratios of Beta Drugs (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
15.29 |
22.82 |
19.57 |
14.82 |
7.26 |
|
| Diluted EPS (Rs.) |
15.29 |
22.82 |
19.57 |
14.82 |
7.26 |
|
| Cash EPS (Rs.) |
22.66 |
27.73 |
26.02 |
20.51 |
12.74 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
127.83 |
120.67 |
100.12 |
80.57 |
65.96 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
127.83 |
120.67 |
100.12 |
80.57 |
65.96 |
|
| Dividend / Share(Rs.) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Revenue from Operations/Share (Rs.) |
218.14 |
205.56 |
164.22 |
129.86 |
82.65 |
|
| PBDIT/Share (Rs.) |
37.26 |
36.67 |
33.54 |
27.09 |
16.56 |
|
| PBIT/Share (Rs.) |
29.88 |
31.76 |
27.09 |
21.40 |
11.08 |
|
| PBT/Share (Rs.) |
20.65 |
30.67 |
26.22 |
20.97 |
10.28 |
|
| Net Profit/Share (Rs.) |
15.29 |
22.82 |
19.57 |
14.82 |
7.26 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
17.07 |
17.83 |
20.42 |
20.85 |
20.03 |
|
| PBIT Margin (%) |
13.69 |
15.44 |
16.49 |
16.47 |
13.40 |
|
| PBT Margin (%) |
9.46 |
14.91 |
15.96 |
16.14 |
12.43 |
|
| Net Profit Margin (%) |
7.00 |
11.10 |
11.91 |
11.41 |
8.78 |
|
| Return on Networth / Equity (%) |
11.95 |
18.90 |
19.54 |
18.39 |
11.00 |
|
| Return on Capital Employed (%) |
11.64 |
24.86 |
25.39 |
24.19 |
15.69 |
|
| Return on Assets (%) |
4.87 |
12.86 |
14.03 |
12.84 |
8.09 |
|
| Total Debt/Equity (X) |
0.96 |
0.03 |
0.04 |
0.07 |
0.06 |
|
| Asset Turnover Ratio (%) |
0.90 |
1.30 |
1.29 |
1.27 |
92.14 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
4.18 |
2.38 |
2.70 |
2.43 |
2.39 |
|
| Quick Ratio (X) |
3.70 |
1.92 |
2.27 |
2.10 |
1.97 |
|
| Inventory Turnover Ratio (X) |
5.00 |
6.70 |
7.81 |
8.64 |
10.33 |
|
| Dividend Payout Ratio (NP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,905.33 |
1,162.52 |
588.67 |
533.23 |
110.99 |
|
| EV/Net Operating Revenue (X) |
8.65 |
5.88 |
3.73 |
4.27 |
1.40 |
|
| EV/EBITDA (X) |
50.66 |
32.97 |
18.26 |
20.48 |
6.97 |
|
| MarketCap/Net Operating Revenue (X) |
8.74 |
6.00 |
3.82 |
4.35 |
1.45 |
|
| Retention Ratios (%) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| Price/BV (X) |
14.91 |
10.22 |
6.26 |
7.02 |
1.82 |
|
| Price/Net Operating Revenue |
8.74 |
6.00 |
3.82 |
4.35 |
1.45 |
|
| Earnings Yield |
0.01 |
0.02 |
0.03 |
0.03 |
0.06 |
|
Source : Dion Global Solutions Limited
